The South Carolina senator led the congressional pack in pharma campaign contributions for the second half of 2021. There are clear reasons.
With an eye to shutting down Medicare drug price negotiations, drug companies and their lobbying groups gave roughly $1.6 million in the first six months of 2021, with Democrats edging closer than they have in a decade to Republicans’ total haul.
Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one of the largest cash hauls in Congress. And it’s only her first term.
Three senators on a revived subcommittee received more than $100,000 each from drugmakers.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.